All articles by Manish Kumar
Manish Kumar
Solventum introduces V.A.C. Peel and Place Dressing wound therapy
The all-in-one dressing and drape, based on the V.A.C. Therapy, is designed to streamline application, cut down on both the time and training needed for dressing changes
CareRing and WellSky team up to enhance care for vulnerable groups
CareRing Health seeks to transform US healthcare by managing chronic conditions at home, reducing costly emergencies, hospitalisations, and nursing home stays, benefiting patients
Athletico Physical Therapy and Limber Health partner to improve patient care and outcomes
Partnership offers patients a hybrid healthcare model, seamlessly connecting the in-clinic therapy experience with innovative digital solutions
EQT to acquire controlling stake in GeBBS Healthcare
GeBBS is a provider of healthcare outsourcing solutions, specialising in revenue cycle management, health information management, and medical billing services
Exactech presents new AI and radiomic research for ortho uses
Exactech showcased AI-driven research in shoulder arthroplasty, highlighting machine learning for predicting outcomes and advances in knee and ankle surgical technologies for improved patient care
LifeBridge Health and care.ai partner to implement Virtual Care Solutions for patients
LifeBridge Health is leveraging care.ai’s Smart Care Facility Platform to enhance patient care, support clinicians, and empower care teams with new virtual care models
FCS uses real-world evidence to enhance blood cancer treatments
FCS’s Real-World Evidence team collaborates with internal and external partners to provide insights that enhance treatment decisions and clinical outcomes using evidence derived from real-world data
AstraZeneca’s TROP2 biomarker platform predicts Dato-DXd outcomes
AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan showed a significantly greater progression-free survival benefit in patients with this biomarker
TC BioPharm intends to launch preclinical studies for treatment of Monkey Pox
TCB008 is an allogeneic unmodified cell therapy that is made up of activated and expanded gamma delta T (GDT) cells which the company expects will have applications in treating the global health emergency
UKRI grants £27m to Dundee researchers for cancer and Parkinson’s research
The funding will support the development of new treatments for conditions like motor neurone disease and Crohn’s by advancing research into cellular signal transmission